Wild type transthyretin amyloidosis: Don't miss diagnosis!

Once considered a rare disease, wild type transthyretin amyloidosis (wtATTR) is currently being recognized as a prevalent disease in the elderly population, as it is estimated to be present in a significant subset of patients with heart failure with preserved ejection fraction (HFpEF) or with degenerative aortic stenosis [1,2]. The increasing population ageing, together with the availability of novel, non-invasive diagnostic tools (namely bone tracer scintigraphy), as well as the growing awareness in the medical community has led to a dramatic increase in the number of diagnosis of wtATTR in the developed countries [3].

Source: International Journal of Cardiology - June 4, 2020 Category: Cardiology Authors: Giuseppe Vergaro, Alain Cohen Solal, Michele Emdin Tags: Editorial Source Type: research